Table 1

Baseline characteristics

Patient characteristicsPre implementation
(N=75)
Post implementation
(N=61)
P value
Index event
 % Admitted for index event (n)68.0 (51)70.5 (43)0.853
 % Weekend presentation (n)17.3 (13)21.3 (13)0.662
Demographics
Mean age in years (SD)66.2 (10.3)67.7 (11.9)0.444
 Median age (range)66 (39–95)68 (33–95)0.342
Race0.377
 % White (n)81.3 (61)75.4 (46)
 % Black (n)14.7 (11)23.0 (14)
 % Asian (n)0.0 (0)0.0 (0)
 % Other (n)0.0 (0)0.0 (0)
 % Unknown (n)4.0 (3)1.6 (1)
% Hispanic ethnicity (n)1.3 (1)0.0 (0)1.000
Past medical history
 % Prior transient ischaemic attacks (n)61.3 (46)60.7 (37)1.000
 % Prior stroke (n)18.7 (14)13.1 (8)0.484
 % Diabetes mellitus (n)44.0 (33)36.1 (22)0.383
 % Atrial fibrillation (n)6.7 (5)14.8 (9)0.159
 % Myocardial infarction (n)2.7 (2)1.6 (1)1.000
 % CABG, PTCA/PCI (n)1.3 (1)0.0 (0)1.000
 % Congestive heart failure (n)10.7 (8)16.4 (10)0.446
 % Pacemaker or AICD (n)6.7 (5)4.9 (3)0.731
 % Valvular heart disease: native or mechanical (n)1.3 (1)4.9 (3)0.325
 % CEA, carotid stent (n)1.3 (1)0.0 (0)1.000
 % COPD (n)13.3 (10)18.0 (11)0.482
 % PVD (n)10.7 (8)9.8 (6)1.000
 % Dementia (n)6.7 (5)11.5 (7)0.373
 % CKD (n)14.7 (11)18.0 (11)0.644
 % Dialysis (n)1.3 (1)0.0 (0)1.000
 % Cancer (n)6.7 (5)13.1 (8)0.248
 % Hypertension (n)66.7 (50)72.1 (44)0.577
 % Hyperlipidaemia (n)58.7 (44)67.2 (41)0.374
 % Arrhythmia (n)5.3 (4)3.3 (2)0.691
 % Speech deficit (n)4.0 (3)9.8 (6)0.298
 % Motor deficit, hemiplegia (n)6.7 (5)23.0 (14)0.011
 % Sleep apnea (n)20.0 (15)39.3 (24)0.022
 % Alcohol dependence (n)2.7 (2)4.9 (3)0.657
 % Depression (n)14.7 (11)32.8 (20)0.014
 % Liver disease (n)2.7 (2)6.6 (4)0.408
 % History of VTE: deep vein thrombosis, PE (n)0.0 (0)4.9 (3)0.088
 % Any major bleeding: emergency department, inpatient admission for bleeding (n)0.0 (0)1.6 (1)0.449
 % Intracranial haemorrhage (n)2.7 (2)4.9 (3)0.657
 % Migraine (n)0.0 (0)4.9 (3)0.088
Baseline medications prior to index event
 % Statin (n)60.0 (45)75.4 (46)0.068
 % Aspirin (n)58.7 (44)59.0 (36)1.000
 % Warfarin (n)1.3 (1)8.2 (5)0.090
 % Anticoagulant (n)6.7 (5)18.0 (11)0.060
 % Clopidogrel (n)6.7 (5)9.8 (6)0.541
 % Any antithrombotic (n)64.0 (48)68.9 (42)0.589
Mean CHADVASC (SD)2.8 (1.4)3.0 (1.4)0.648
Mean HASBLED (SD)2.0 (1.2)2.2 (1.1)0.242
Charlson: mean±SD2.6 (2.3)2.8 (2.6)0.515
 Median Charlson (range)2 (0–9)3 (0–14)0.563
% Smoker (n)41.3 (31)21.3 (13)0.017
  • AICD, automatic implantable cardioverter-defibrillator ; CABG, coronary artery bypass grafting; CEA, carotid endarterectomy; CHADVASC, score that includes congestive heart failure, hypertension, age >75, diabetes, prior stroke or TIA ; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HASBLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly; PCI, percutaneous coronary intervention; PCTA, percutaneous transluminal coronary angioplasty; PE, pulmonary embolism; PVD, peripheral vascular disease; VTE, venous thromboembolism .